76 related articles for article (PubMed ID: 24762480)
21. Effects of surfactants on the properties of PLGA nanoparticles.
Menon JU; Kona S; Wadajkar AS; Desai F; Vadla A; Nguyen KT
J Biomed Mater Res A; 2012 Aug; 100(8):1998-2005. PubMed ID: 22566409
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
23. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
Narvekar M; Xue HY; Wong HL
Int J Pharm; 2012 Oct; 436(1-2):721-31. PubMed ID: 22850294
[TBL] [Abstract][Full Text] [Related]
24. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
25. Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
Subia B; Kundu SC
Nanotechnology; 2013 Jan; 24(3):035103. PubMed ID: 23262833
[TBL] [Abstract][Full Text] [Related]
26. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
28. Herceptin-decorated salinomycin-loaded nanoparticles for breast tumor targeting.
Aydın RS
J Biomed Mater Res A; 2013 May; 101(5):1405-15. PubMed ID: 23086911
[TBL] [Abstract][Full Text] [Related]
29. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
Thamake SI; Raut SL; Gryczynski Z; Ranjan AP; Vishwanatha JK
Biomaterials; 2012 Oct; 33(29):7164-73. PubMed ID: 22795543
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
[TBL] [Abstract][Full Text] [Related]
31. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
32. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
33. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
[TBL] [Abstract][Full Text] [Related]
34. Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination.
Osman R; Kan PL; Awad G; Mortada N; El-Shamy AE; Alpar O
Int J Pharm; 2011 Apr; 408(1-2):257-65. PubMed ID: 21335080
[TBL] [Abstract][Full Text] [Related]
35. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
36. PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation.
Van de Ven H; Vermeersch M; Matheeussen A; Vandervoort J; Weyenberg W; Apers S; Cos P; Maes L; Ludwig A
Int J Pharm; 2011 Nov; 420(1):122-32. PubMed ID: 21864661
[TBL] [Abstract][Full Text] [Related]
37. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
Lin R; Shi Ng L; Wang CH
Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
[TBL] [Abstract][Full Text] [Related]
38. PLGA/polymeric liposome for targeted drug and gene co-delivery.
Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
[TBL] [Abstract][Full Text] [Related]
39. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
40. Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel.
Kulhari H; Pooja D; Shrivastava S; V G M N; Sistla R
Colloids Surf B Biointerfaces; 2014 May; 117():166-73. PubMed ID: 24632389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]